News & Media :: Vedanta Biosciences, Inc.

Nov 24, 2020

Vedanta Biosciences Appoints Troy Ignelzi, Chief Financial Officer at Karuna Therapeutics, to its Board of Directors

Recent News

Nov 20, 2020

Can patients’ gut microbes help fight cancer?

Oct 12, 2020

Vedanta Biosciences Announces Additional Pharmacokinetics Data from Phase 1 Study of VE202 for Inflammatory Bowel Disease to be Presented at United European Gastroenterology Week 2020

Sep 30, 2020

Vedanta Biosciences Awarded Up to $76.9 Million Including $7.4 Million Upfront from BARDA to Advance the Development of VE303, a Defined Bacterial Consortium for Prevention of C. difficile Infection in High-Risk Patients

Sep 16, 2020

Vedanta Biosciences Announces the Appointment of Jeffrey Silber, M.D. as Chief Medical Officer

View All News View All Press Releases